Private Equity group Siparex (Paris, France) has taken a minority stake in Pharmactive (Spain), a company specializing in the research,
development and extraction of branded natural ingredients.
Pharmactive, a science-based botanical ingredient leader, said it continues to experience a strong growth and development curve, which has only accelerated since 2017. The company has logged an average annual sales growth greater than 23 percent, driven primarily by the success of its premium products affron saffron extract and ABG10+, a pioneering black garlic extract. The company forecasts sales of around €12 million by the end of fiscal 2021.
The transaction with Siparex Midcap will allow Pharmactive to accelerate its development plans through external growth and expand its portfolio of natural ingredients and international commercial presence. Approximately 85 percent of Pharmactive’s global activity occurs outside Spain: in Europe, the U.S. and Asia.
“It’s exciting to collaborate with such a well-established PE,” said Jean-Marie Raymond, CEO and founder of Pharmactive. “This new investment round marks a significant milestone for our company. We experienced expansive growth in 2020, despite the pandemic, and strong sales growth is forecast to continue in 2021.”
“Positioned in a booming market, Pharmactive is an innovative company led by an experienced and enthusiastic founding manager,” said Pierre Bordeaux Montrieux, managing director of Siparex Midcap.
“Pharmactive stands out in particular with its validation positioning and systematic scientific analysis of premium products,” added Stéphane Agaësse, senior investment manager within Siparex Midcap. “We are proud to support them in this new phase of development.”
Founded in 2009 by Raymond, Pharmactive specializes in high-end natural plant-based ingredients (such as the aforementioned saffron and black garlic) for the food supplement industry. In order to ensure the high quality of its products, Pharmactive has developed validation by scientific studies and research. Its in-house laboratories focus on the investigation of plant cultivation, extraction of active ingredients and control across the entire upstream value chain.
“Consumers are seeking science-supported, natural mental wellness solutions and Pharmactive can fulfill this demand and other emerging trends with branded ingredients backed by science,” said Raymond. “Pharmactive brings innovation, nature and value to the table, challenging current paradigms.”
For more information, visit www.pharmactive.eu.
